Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
RecruitingNot a traditional drug phaseinterventionalRules rewrite
Not a traditional drug phase: pathway care for Endometriosis, Pain
Endometriosis surgery is required when medical treatment fails to release women from pain. However, complete surgery does not work every time to improve patients' symptoms.
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
If you join, the listed intervention(s) are pathway care. The registry lists allocation as randomized. Endometriosis surgery is required when medical treatment fails to release women from pain.
They plan to enroll about 187 people at 9 sites. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
ENDometriosis: Evaluation of Detection and Need for ALGOlogic Care Before Surgery
Interventions: pathway care
Primary outcome (registry wording): Evaluation of quality of life
Who it is for (from inclusion criteria)
Ages 18 Years to 50 Years
Women only
Maternal age from 18 up to 50 years old (50 non included)
Women affiliated to social coverage insurance
Women who understand French
Women who signed the written consent
Women with impaired quality of life (pain) linked to endometriosis
Women with formal radiological signs of endometriosis (MRI lesions more than 5 mm or endometrioma more than 20 mm on radiological examinations)
Surgical indication for resection of lesions by laparoscopy or robotic surgery for management of pain or impairment of quality of life
Who the registry excludes
Women undergoing surgery for the purpose of infertility
Patient with previous surgery for removal of deep lesions of endometriosis or endometriotic cysts (history of exploratory laparoscopy accepted)
Patient with suspicious lesions on MRI or specialized ultrasound
A patient who needs to be treated for another uterine pathology at the same time
Patient with a desire for pregnancy immediately and/or within one year after surgery
Women who refuse clinical examination (some algological tests couldn't be performed without clinical examination)
Patient who has already received algological treatment or who should receive it before surgery
This early phase I trial compares the side effects between patients treated with proton radiation therapy versus intensity modulated radiation therapy after surgery for the treatment of endometrial or cervical cancer. Radiation therapy uses high energy protons or x-rays to kill tumor cells and shrink tumors.
The goal of this watch-and-measure (no experimental treatment required) study is to determine the clinical validity of a deep neural network algorithm that utilizes protein biomarker detection of Endometriosis - "EndoCheck" - as an "aid in diagnosis" for endometriosis and to show validity as a diagnostic test
Endometriosis, a chronic gynecological disorder associated with pain and infertility, is a common condition affecting approximately one in ten women. Up to 50% of patients with endometriosis have ovarian endometriomas (or "chocolate cysts").
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT06997809?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT06997809?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.